Back to Journals » Advances and Applications in Bioinformatics and Chemistry » Volume 5

Contact-based ligand-clustering approach for the identification of active compounds in virtual screening

Authors Mantsyzov, Bouvier, Evrard-Todeschi, Bertho G

Received 15 February 2012

Accepted for publication 5 April 2012

Published 6 September 2012 Volume 2012:5 Pages 61—79

DOI https://doi.org/10.2147/AABC.S30881

Review by Single anonymous peer review

Peer reviewer comments 7



Alexey B Mantsyzov,1 Guillaume Bouvier,2 Nathalie Evrard-Todeschi,1 Gildas Bertho1

1Université Paris Descartes, Sorbonne, Paris, France; 2Institut Pasteur, Paris, France

Abstract: Evaluation of docking results is one of the most important problems for virtual screening and in silico drug design. Modern approaches for the identification of active compounds in a large data set of docked molecules use energy scoring functions. One of the general and most significant limitations of these methods relates to inaccurate binding energy estimation, which results in false scoring of docked compounds. Automatic analysis of poses using self-organizing maps (AuPosSOM) represents an alternative approach for the evaluation of docking results based on the clustering of compounds by the similarity of their contacts with the receptor. A scoring function was developed for the identification of the active compounds in the AuPosSOM clustered dataset. In addition, the AuPosSOM efficiency for the clustering of compounds and the identification of key contacts considered as important for its activity, were also improved. Benchmark tests for several targets revealed that together with the developed scoring function, AuPosSOM represents a good alternative to the energy-based scoring functions for the evaluation of docking results.

Keywords: scoring, docking, virtual screening, CAR, AuPosSOM

Creative Commons License © 2012 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.